Hydroxymethylglutaryl-CoA Reductase Inhibitors
"Hydroxymethylglutaryl-CoA Reductase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis.
Descriptor ID |
D019161
|
MeSH Number(s) |
D27.505.519.186.071.202.370 D27.505.519.389.370 D27.505.954.557.500.202.370
|
Concept/Terms |
Hydroxymethylglutaryl-CoA Reductase Inhibitors- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Hydroxymethylglutaryl CoA Reductase Inhibitors
- Inhibitors, Hydroxymethylglutaryl-CoA Reductase
- Reductase Inhibitors, Hydroxymethylglutaryl-CoA
- Inhibitors, HMG-CoA Reductase
- Inhibitors, HMG CoA Reductase
- Reductase Inhibitors, HMG-CoA
- HMG-CoA Reductase Inhibitors
- HMG CoA Reductase Inhibitors
- Statins, HMG-CoA
- HMG-CoA Statins
- Statins, HMG CoA
- Inhibitors, Hydroxymethylglutaryl-CoA
- Hydroxymethylglutaryl-CoA Inhibitors
- Inhibitors, Hydroxymethylglutaryl CoA
- Statins
- Inhibitors, Hydroxymethylglutaryl-Coenzyme A
- Hydroxymethylglutaryl-Coenzyme A Inhibitors
- Inhibitors, Hydroxymethylglutaryl Coenzyme A
|
Below are MeSH descriptors whose meaning is more general than "Hydroxymethylglutaryl-CoA Reductase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Hydroxymethylglutaryl-CoA Reductase Inhibitors".
This graph shows the total number of publications written about "Hydroxymethylglutaryl-CoA Reductase Inhibitors" by people in this website by year, and whether "Hydroxymethylglutaryl-CoA Reductase Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 1 | 2 |
1996 | 1 | 2 | 3 |
1997 | 1 | 1 | 2 |
1998 | 3 | 0 | 3 |
1999 | 2 | 1 | 3 |
2000 | 3 | 1 | 4 |
2001 | 2 | 0 | 2 |
2002 | 5 | 0 | 5 |
2003 | 8 | 6 | 14 |
2004 | 11 | 6 | 17 |
2005 | 18 | 1 | 19 |
2006 | 17 | 6 | 23 |
2007 | 21 | 8 | 29 |
2008 | 17 | 3 | 20 |
2009 | 12 | 2 | 14 |
2010 | 16 | 5 | 21 |
2011 | 15 | 9 | 24 |
2012 | 13 | 2 | 15 |
2013 | 25 | 3 | 28 |
2014 | 22 | 11 | 33 |
2015 | 19 | 8 | 27 |
2016 | 23 | 14 | 37 |
2017 | 16 | 5 | 21 |
2018 | 29 | 6 | 35 |
2019 | 35 | 14 | 49 |
2020 | 11 | 7 | 18 |
2021 | 34 | 6 | 40 |
2022 | 29 | 0 | 29 |
2023 | 27 | 1 | 28 |
2024 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hydroxymethylglutaryl-CoA Reductase Inhibitors" by people in Profiles.
-
Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial. Eur Heart J. 2024 Apr 01; 45(13):1173-1176.
-
Impact of Bempedoic Acid on Total Cardiovascular Events: A Prespecified Analysis of the CLEAR Outcomes Randomized Clinical Trial. JAMA Cardiol. 2024 Mar 01; 9(3):245-253.
-
LDL-C Lowering in Prevention of Atherosclerotic Cardiovascular Disease: Another Step Forward in This Lifelong Marathon. J Am Coll Cardiol. 2024 Feb 13; 83(6):665-668.
-
Statins and BCG response: Is there more to the story? Scott Med J. 2024 Feb; 69(1):1-2.
-
New Clinical Challenges for Health Providers in the Prescription of Statins in the Elderly. Am J Med. 2024 Mar; 137(3):189-191.
-
The 2022 American College of Cardiology Expert Consensus on the Role of Nonstatin Therapies: An Expert-Guided Tour. Tex Heart Inst J. 2023 11 17; 50(6).
-
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 European Society of Cardiology Congress. Curr Atheroscler Rep. 2023 Dec; 25(12):965-978.
-
Long-Term Mortality in Patients With Severe Hypercholesterolemia Phenotype From a Racial and Ethnically Diverse US Cohort. Circulation. 2024 02 06; 149(6):417-426.
-
Nurse Practitioner Care Compared with Primary Care or Nephrologist Care in Early CKD. Clin J Am Soc Nephrol. 2023 12 01; 18(12):1533-1544.
-
Statin Use and Chemoradiation in Esophageal Squamous Cell Carcinomas: Ready for Prime Time? J Thorac Oncol. 2023 08; 18(8):970-971.